224 related articles for article (PubMed ID: 25270066)
1. Renal glycosphingolipid metabolism is dysfunctional in lupus nephritis.
Nowling TK; Mather AR; Thiyagarajan T; Hernández-Corbacho MJ; Powers TW; Jones EE; Snider AJ; Oates JC; Drake RR; Siskind LJ
J Am Soc Nephrol; 2015 Jun; 26(6):1402-13. PubMed ID: 25270066
[TBL] [Abstract][Full Text] [Related]
2. Targeting glycosphingolipid metabolism as a potential therapeutic approach for treating disease in female MRL/lpr lupus mice.
Nowling TK; Rodgers J; Thiyagarajan T; Wolf B; Bruner E; Sundararaj K; Molano I; Gilkeson G
PLoS One; 2020; 15(3):e0230499. PubMed ID: 32187230
[TBL] [Abstract][Full Text] [Related]
3. FLI1 Levels Impact CXCR3 Expression and Renal Infiltration of T Cells and Renal Glycosphingolipid Metabolism in the MRL/lpr Lupus Mouse Strain.
Sundararaj KP; Thiyagarajan T; Molano I; Basher F; Powers TW; Drake RR; Nowling TK
J Immunol; 2015 Dec; 195(12):5551-60. PubMed ID: 26538397
[TBL] [Abstract][Full Text] [Related]
4. Neuraminidase activity mediates IL-6 production by activated lupus-prone mesangial cells.
Sundararaj K; Rodgers JI; Marimuthu S; Siskind LJ; Bruner E; Nowling TK
Am J Physiol Renal Physiol; 2018 Apr; 314(4):F630-F642. PubMed ID: 29357434
[TBL] [Abstract][Full Text] [Related]
5. The role of neuraminidase in TLR4-MAPK signalling and the release of cytokines by lupus serum-stimulated mesangial cells.
Sundararaj K; Rodgers J; Angel P; Wolf B; Nowling TK
Immunology; 2021 Apr; 162(4):418-433. PubMed ID: 33314123
[TBL] [Abstract][Full Text] [Related]
6. The role of neuraminidase 1 (NEU1) in cytokine release by primary mouse mesangial cells and disease outcomes in murine lupus nephritis.
Rodgers J; Sundararaj K; Bruner E; Wolf B; Nowling TK
Autoimmunity; 2021 May; 54(3):163-175. PubMed ID: 33749450
[TBL] [Abstract][Full Text] [Related]
7. Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.
Jiang C; Zhao ML; Scearce RM; Diaz M
Arthritis Rheum; 2011 Apr; 63(4):1086-96. PubMed ID: 21225690
[TBL] [Abstract][Full Text] [Related]
8. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
[TBL] [Abstract][Full Text] [Related]
9. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.
Anders HJ; Vielhauer V; Eis V; Linde Y; Kretzler M; Perez de Lema G; Strutz F; Bauer S; Rutz M; Wagner H; Gröne HJ; Schlöndorff D
FASEB J; 2004 Mar; 18(3):534-6. PubMed ID: 14734643
[TBL] [Abstract][Full Text] [Related]
10. Circulating CSF-1 promotes monocyte and macrophage phenotypes that enhance lupus nephritis.
Menke J; Rabacal WA; Byrne KT; Iwata Y; Schwartz MM; Stanley ER; Schwarting A; Kelley VR
J Am Soc Nephrol; 2009 Dec; 20(12):2581-92. PubMed ID: 19926892
[TBL] [Abstract][Full Text] [Related]
11. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
[TBL] [Abstract][Full Text] [Related]
12. Complement factor H deficiency accelerates development of lupus nephritis.
Bao L; Haas M; Quigg RJ
J Am Soc Nephrol; 2011 Feb; 22(2):285-95. PubMed ID: 21148254
[TBL] [Abstract][Full Text] [Related]
13. IL-34-Dependent Intrarenal and Systemic Mechanisms Promote Lupus Nephritis in MRL-
Wada Y; Gonzalez-Sanchez HM; Weinmann-Menke J; Iwata Y; Ajay AK; Meineck M; Kelley VR
J Am Soc Nephrol; 2019 Feb; 30(2):244-259. PubMed ID: 30622154
[TBL] [Abstract][Full Text] [Related]
14. Function of the Th17/interleukin-17A immune response in murine lupus nephritis.
Schmidt T; Paust HJ; Krebs CF; Turner JE; Kaffke A; Bennstein SB; Koyro T; Peters A; Velden J; Hünemörder S; Haag F; Steinmetz OM; Mittrücker HW; Stahl RA; Panzer U
Arthritis Rheumatol; 2015 Feb; 67(2):475-87. PubMed ID: 25385550
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of FoxO3a expression through PI3K/Akt pathway attenuates the progression of lupus nephritis in MRL/lpr mice.
Zhao C; Gu Y; Chen L; Su X
Int Immunopharmacol; 2020 Dec; 89(Pt A):107027. PubMed ID: 33039957
[TBL] [Abstract][Full Text] [Related]
16. Microthrombotic Renal Vascular Lesions Are Associated to Increased Renal Inflammatory Infiltration in Murine Lupus Nephritis.
Gonzalo-Gil E; García-Herrero C; Toldos O; Usategui A; Criado G; Pérez-Yagüe S; Barber DF; Pablos JL; Galindo M
Front Immunol; 2018; 9():1948. PubMed ID: 30210500
[No Abstract] [Full Text] [Related]
17. Involvement of infiltrating macrophage-derived activin A in the progression of renal damage in MRL-lpr mice.
Kadiombo AT; Maeshima A; Kayakabe K; Ikeuchi H; Sakairi T; Kaneko Y; Hiromura K; Nojima Y
Am J Physiol Renal Physiol; 2017 Feb; 312(2):F297-F304. PubMed ID: 27881396
[TBL] [Abstract][Full Text] [Related]
18. Enhanced tubular epithelial CD44 expression in MRL-lpr lupus nephritis.
Benz PS; Fan X; Wüthrich RP
Kidney Int; 1996 Jul; 50(1):156-63. PubMed ID: 8807584
[TBL] [Abstract][Full Text] [Related]
19. Effect of mycophenolate mofetil on severity of nephritis and nitric oxide production in lupus-prone MRL/lpr mice.
Lui SL; Tsang R; Wong D; Chan KW; Chan TM; Fung PC; Lai KN
Lupus; 2002; 11(7):411-8. PubMed ID: 12195781
[TBL] [Abstract][Full Text] [Related]
20. IL-3 contributes to development of lupus nephritis in MRL/lpr mice.
Renner K; Hermann FJ; Schmidbauer K; Talke Y; Rodriguez Gomez M; Schiechl G; Schlossmann J; Brühl H; Anders HJ; Mack M
Kidney Int; 2015 Nov; 88(5):1088-98. PubMed ID: 26131743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
